Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04911270 · ClinicalTrials.gov registry record · NA
Clinical Decision Support Tool for Vancomycin Dosing in Children
A NA study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- NA
- Development phase
- 75
- Enrollment target
NCT04911270 is a NA study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 75 participants.
The verdict
NCT04911270, a NA study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
Study Summary
This study will evaluate the pharmacokinetic and pharmacodynamic dosing properties of intravenous vancomycin in pediatric patients using a novel computer decision support (CDS) tool called Lyv. Dosing will be individualized based on AUC24/MIC. The results will be compared to matched historical controls.
Interventions
- DEVICE Computer Decision Support Tool Intervention Group
- OTHER Matched Historical Controls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2022-05-09 |
| Est. Completion | 2025-05-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04911270
The ClinicalTrials.gov registry entry for NCT04911270 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Computer Decision Support Tool Intervention Group is the first listed.
NCT04911270 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04911270 about?
NCT04911270 is a clinical study titled "Clinical Decision Support Tool for Vancomycin Dosing in Children". This study will evaluate the pharmacokinetic and pharmacodynamic dosing properties of intravenous vancomycin in pediatric patients using a novel computer decision support (CDS) tool called Lyv. Dosing will be individualized based on AUC24/MIC. The results will be compared to matched historical contr...
What is the current status of trial NCT04911270?
This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2022-05-09. Estimated completion is 2025-05-10.
What interventions are being tested in trial NCT04911270?
The interventions under investigation include: Computer Decision Support Tool Intervention Group (DEVICE), Matched Historical Controls (OTHER).
Who is sponsoring clinical trial NCT04911270?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.